These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27214037)

  • 1. Acute ischemic stroke after cardiac catheterization: the protamine low-dose recombinant tissue plasminogen activator pathway.
    Guevara C; Quijada A; Rosas C; Bulatova K; Lara H; Nieto E; Morales M
    Blood Coagul Fibrinolysis; 2017 Apr; 28(3):261-263. PubMed ID: 27214037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis After Protamine Reversal of Heparin for Acute Ischemic Stroke After Cardiac Catheterization: Case Report and Literature Review.
    Warner DS; Schwartz BG; Babygirija R; Rovin RA; Kassam AB; Biddick L; Sajjad R; Chohan A; Panichpisal K
    Neurologist; 2018 Nov; 23(6):194-196. PubMed ID: 30379743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review.
    Ranasinghe T; Mays T; Quedado J; Adcock A
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104283. PubMed ID: 31324409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.
    Fontaine GV; Smith SM
    Pharmacotherapy; 2017 Oct; 37(10):e103-e106. PubMed ID: 28741720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of thrombolysis for strokes after cardiac catheterization.
    Khatri P; Taylor RA; Palumbo V; Rajajee V; Katz JM; Chalela JA; Geers A; Haymore J; Kolansky DM; Kasner SE;
    J Am Coll Cardiol; 2008 Mar; 51(9):906-11. PubMed ID: 18308158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study.
    Paciaroni M; Balucani C; Agnelli G; Caso V; Silvestrelli G; Grotta JC; Demchuk AM; Sohn SI; Orlandi G; Leys D; Pezzini A; Alexandrov AV; Silvestrini M; Fofi L; Barlinn K; Inzitari D; Ferrarese C; Tassi R; Tsivgoulis G; Consoli D; Baldi A; Bovi P; Luda E; Galletti G; Invernizzi P; DeLodovici ML; Corea F; Del Sette M; Monaco S; Marcheselli S; Alberti A; Venti M; Acciarresi M; D'Amore C; Macellari F; Lanari A; Previdi P; Gonzales NR; Pandurengan RK; Vahidy FS; Sline M; Bal SS; Chiti A; Gialdini G; Dumont F; Cordonnier C; Debette S; Padovani A; Cerqua R; Bodechtel U; Kepplinger J; Nesi M; Nencini P; Beretta S; Trentini C; Martini G; Piperidou C; Heliopoulos I; D'Anna S; Cappellari M; Donati E; Bono G; Traverso E; Toni D
    Stroke; 2012 Jan; 43(1):125-30. PubMed ID: 22034003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008.
    Salam KA; Ummer K; Kumar VG; Noone ML; Laila A; Ragini J
    J Clin Neurosci; 2009 Oct; 16(10):1276-8. PubMed ID: 19570685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of intravenous thrombolysis is increasing in the United States.
    Nasr DM; Brinjikji W; Cloft HJ; Rabinstein AA
    Int J Stroke; 2013 Dec; 8(8):681-8. PubMed ID: 22882725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.
    Walters MR; Muir KW; Harbison J; Lees KR; Ford GA
    Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Tissue Plasminogen Activator as Provocateur of Myocardial Infarction.
    Burlen J; Cholin L; Ruzieh M; Dasa O
    Am J Ther; 2017; 24(4):e489-e490. PubMed ID: 27574925
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting thrombolysis in acute ischemic stroke.
    Dirks M; Niessen LW; van Wijngaarden JD; Koudstaal PJ; Franke CL; van Oostenbrugge RJ; Huijsman R; Lingsma HF; Minkman MM; Dippel DW;
    Stroke; 2011 May; 42(5):1325-30. PubMed ID: 21393587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolysis in acute ischemic stroke with intravenous recombinant tissue-type plasminogen activator].
    May Z; Kakuk I; Ováry C; Ricsóy G; Skopál J; Szegedi N; Varga D; Nagy Z
    Orv Hetil; 2002 Nov; 143(44):2479-84. PubMed ID: 12674802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.